16 Jan 2024 KU Leuven researchers discover how to break the negative feedback loop to improve cancer immunotherapy Member news
20 Dec 2023 argenx reports topline results from ADDRESS study of efgartigimod SC in pemphigus Member news
20 Dec 2023 Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufactured BCMA CAR-T candidate, GLPG5301 Member news
29 Nov 2023 Sequana Medical announces positive data from non-randomized cohort in US Phase 1/2a MOJAVE study of DSR® 2.0 for treatment of heart failure Member news
28 Nov 2023 argenx reports topline results from ADVANCE-SC study of VYVGART Hytrulo in primary immune thrombocytopenia Member news
15 Nov 2023 Orionis Biosciences announces first patient dosed in Phase 1 clinical trial of ORB-011 in patients with advanced solid tumors Member news
14 Nov 2023 SwiftPharma and PlantForm target blockbuster cancer drug with new contract manufacturing agreement for plant-made biosimilars Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
